Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J4PM
|
||||
| Former ID |
DIB009531
|
||||
| Drug Name |
NNC-0151-0000-0000
|
||||
| Synonyms |
Neutrazumab; NN-8209; Anti-C5aR monoclonal antibodies (rheumatoid arthritis/SLE), G2/Novo Nordisk
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06] | Phase 2 | [529141] | ||
| Company |
G2 Therapies Ltd
|
||||
| Target and Pathway | |||||
| Target(s) | Complement C5 | Target Info | [529141] | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.